Jonathan L Silberstein
Overview
Explore the profile of Jonathan L Silberstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
828
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pincus J, Greenberg J, Natale C, Koller C, Miller S, Silberstein J, et al.
Oncologist
. 2022 Aug;
28(2):149-156.
PMID: 35920550
Introduction: This study aimed to evaluate if race impacted outcomes or risk of disease progression in men on active surveillance (AS) for prostate cancer. We present the results from our...
2.
Greenberg J, Leinwand G, Feibus A, Haney N, Krane L, Thomas R, et al.
Urology
. 2020 Nov;
148:203-210.
PMID: 33166542
Objective: To evaluate the risk upgrading of active surveillance (AS), we reviewed the outcomes of African American men (AA) after electing AS. AS is the standard of care for men...
3.
Shelton T, Greenberg J, Silberstein J, Krane L
Aging Male
. 2020 Jun;
23(5):1400-1408.
PMID: 32500781
Introduction: Neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte ratios (PLR) are useful clinical biomarkers for prognosis in several malignancies. Their predictive value has been less clearly demonstrated with prostate cancer (PCa), particularly, their...
4.
Natale C, Leinwand G, Zeineddine F, Silberstein J, Krane L
Cancer Treat Res Commun
. 2020 May;
24:100177.
PMID: 32454387
Background: Although emerging evidence demonstrates increased risk of secondary bladder cancer following pelvic radiotherapy, the aggressiveness of these tumors is not well-characterized. Materials And Methods: A search of the Surveillance,...
5.
Scherzer N, Greenberg J, Shaw E, Silberstein J, Thomas R, Krane L
J Robot Surg
. 2019 Oct;
14(4):615-619.
PMID: 31586270
Development of ureteroanastamotic strictures (UAS) after urinary diversion is not uncommon, but is challenging to treat. Poor outcomes are likely with endoscopic and radiologic management, and definitive surgical treatment can...
6.
Cao S, Ma T, Ungerleider N, Roberts C, Kobelski M, Jin L, et al.
Oncogene
. 2019 Aug;
38(45):7060-7072.
PMID: 31409897
Deregulated expression of circular RNAs (circRNAs) is associated with various human diseases, including many types of cancer. Despite their growing links to cancer, there has been limited characterization of circRNAs...
7.
Natale C, Leinwand G, Chiang J, Silberstein J, Krane L
Clin Genitourin Cancer
. 2019 Aug;
17(5):380-388.
PMID: 31395362
Introduction: The objective of this study was to characterize the demographic, prognostic, and treatment factors for patients with primary adenocarcinoma of the bladder by analyzing the impact of histologic subtype...
8.
Leinwand G, Gabrielson A, Krane L, Silberstein J
Transl Androl Urol
. 2018 Oct;
7(Suppl 4):S397-S410.
PMID: 30363480
Active surveillance (AS) is a treatment modality for prostate cancer that aims to simultaneously avoid overtreatment and allow for the timely intervention of localized disease. AS has become the de...
9.
Waterhouse Jr R, Van Neste L, Moses K, Barnswell C, Silberstein J, Jalkut M, et al.
Urology
. 2018 Apr;
128:62-65.
PMID: 29660369
Objective: To evaluate an epigenetic assay performed on tissue from negative prostate biopsies in a group of African American (AA) men undergoing repeat biopsy, and to compare accuracy for predicting...
10.
Punnen S, Freedland S, Polascik T, Loeb S, Risk M, Savage S, et al.
J Urol
. 2017 Dec;
199(6):1459-1463.
PMID: 29223389
Purpose: The 4Kscore® test accurately detects aggressive prostate cancer and reduces unnecessary biopsies. However, its performance in African American men has been unknown. We assessed test performance in a cohort...